@article{article, title  = {{Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2017}},

 month = {{12}},

 author = {{Martin M and Holmes FA and Ejlertsen B and Delaloge S and Moy B and Iwata H and von Minckwitz G and Chia SKL and Mansi J and Barrios CH and Gnant M et al}},

 doi = {{10.1016/s1470-2045(17)30717-9}},

 volume = {{18}},

 journal = {{The Lancet Oncology}},

 issue = {{12}},

 pages = {{1688-1700}},

 note = {{Accessed on 2025/10/10}}}